Proteus Biomedical

Proteus Digital Health Proteus Digital Health published a paper on its ingestible sensor that explains the design of the sensor, the safety tests Proteus completed, and the clinical trials Proteus conducted with 412 patients who used the system over 5,656 days.

Digital medicine company Proteus Digital Health has raised an additional $52 million from undisclosed investors following a whopping $120 million raise the company announced just last month.

Proteus Digital Health has raised $120 million from new, undisclosed investors described as "major new institutional investors based in the United States, Europe and Asia.